Literature DB >> 22752254

The relationship between glucose metabolism disorders and malignant thyroid disease.

Ayse Ocak Duran1, Cüneyd Anil, Alptekin Gursoy, Aslı Nar, Ozden Altundag, Neslihan Bascil Tutuncu.   

Abstract

BACKGROUND: Previous studies have shown a positive relationship between insulin resistance and several common adult cancers. The present retrospective study aimed to investigate the association between glucose metabolism disorders (GMDs) and the prevalence of thyroid cancer.
METHODS: We investigated the data of 4272 patients who had undergone fine-needle aspiration biopsy (FNAB) of thyroid nodules. The biopsy results were evaluated as diagnostic or non-diagnostic and the diagnostic results were classified as benign, malignant, and indeterminate. In this study, we included 2234 of the above patients who had undergone FNAB at our hospital and whose biopsy results were evaluated as diagnostic and were classified as either benign or malignant. We obtained the cytologic data and the glucose metabolism status of these patients retrospectively.
RESULTS: Of the 2234 patients, 629 (28.1 %) had GMD (impaired fasting glucose, impaired glucose tolerance). Malignant cytology was determined in 106 (4.7 %) patients overall. Of the 629 patients with GMD, 582 (92.5 %) patients had benign cytology and 47 (7.5 %) patients had malignant cytology. Fifty-nine (3.7 %) of the 1605 normoglycemic patients had malignant cytology. Malignant cytology was determined more frequently ın the patients who had GMDs (p < 0.001).
CONCLUSION: The results demonstrated that thyroid cancer prevalence was higher in patients with GMD. According to our results, GMD should be considered as a risk factor for malignancy in the evaluation of thyroid nodules.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752254     DOI: 10.1007/s10147-012-0435-3

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  27 in total

1.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

2.  Diabetes mellitus and risk of colorectal cancer: a meta-analysis.

Authors:  Susanna C Larsson; Nicola Orsini; Alicja Wolk
Journal:  J Natl Cancer Inst       Date:  2005-11-16       Impact factor: 13.506

3.  American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.

Authors:  Hossein Gharib; Enrico Papini; Roberto Valcavi; H Jack Baskin; Anna Crescenzi; Massimo E Dottorini; Daniel S Duick; Rinaldo Guglielmi; Carlos Robert Hamilton; Martha A Zeiger; Michele Zini
Journal:  Endocr Pract       Date:  2006 Jan-Feb       Impact factor: 3.443

4.  Prospective study of hyperglycemia and cancer risk.

Authors:  Pär Stattin; Ove Björ; Pietro Ferrari; Annekatrin Lukanova; Per Lenner; Bernt Lindahl; Göran Hallmans; Rudolf Kaaks
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

5.  Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.

Authors:  K Boelaert; J Horacek; R L Holder; J C Watkinson; M C Sheppard; J A Franklyn
Journal:  J Clin Endocrinol Metab       Date:  2006-07-25       Impact factor: 5.958

6.  Introducing the thyroid gland as another victim of the insulin resistance syndrome.

Authors:  Jorge Rezzonico; Mariana Rezzonico; Eduardo Pusiol; Fabián Pitoia; Hugo Niepomniszcze
Journal:  Thyroid       Date:  2008-04       Impact factor: 6.568

7.  Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria.

Authors:  K Rapp; J Schroeder; J Klenk; H Ulmer; H Concin; G Diem; W Oberaigner; S K Weiland
Journal:  Diabetologia       Date:  2006-03-24       Impact factor: 10.122

8.  Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer.

Authors:  Geoffrey C Kabat; Mimi Kim; Bette J Caan; Rowan T Chlebowski; Marc J Gunter; Gloria Y F Ho; Beatriz L Rodriguez; James M Shikany; Howard D Strickler; Mara Z Vitolins; Thomas E Rohan
Journal:  Int J Cancer       Date:  2009-12-01       Impact factor: 7.396

Review 9.  The IGF-I axis in thyroid carcinoma.

Authors:  A Ciampolillo; C De Tullio; E Perlino; E Maiorano
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

10.  Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies.

Authors:  R Huxley; A Ansary-Moghaddam; A Berrington de González; F Barzi; M Woodward
Journal:  Br J Cancer       Date:  2005-06-06       Impact factor: 7.640

View more
  4 in total

1.  An assessment of the relationship between thyroid nodule characteristics, insulin resistance and arterial stiffness in euthyroid nodular goiter.

Authors:  Yasemin Aydoğan; Mustafa Altay; Oktay Ünsal; Veysel Kaplanoğlu; Yavuz Çağır; Canan Yıldız; Esin Beyan; Selma Uysal Ramadan
Journal:  Endocrine       Date:  2018-08-06       Impact factor: 3.633

2.  Diabetes mellitus and risk of thyroid cancer: a meta-analysis.

Authors:  Yohwan Yeo; Seung-Hyun Ma; Yunji Hwang; Pamela L Horn-Ross; Ann Hsing; Kyu-Eun Lee; Young Joo Park; Do-Joon Park; Keun-Young Yoo; Sue K Park
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

Review 3.  Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?

Authors:  Roberta Malaguarnera; Veronica Vella; Maria Luisa Nicolosi; Antonino Belfiore
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-14       Impact factor: 5.555

4.  Abnormal Glucose Metabolism Parameters and the Aggressiveness of Differentiated Thyroid Carcinoma: A Hospital-Based Cross-Section Study in China.

Authors:  Junyu Zhao; Yutian Tian; Zhen Jia; Jinming Yao; Lin Liao; Jianjun Dong
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-01       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.